MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2. (Q39551048)

13 September 2017

title

MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2. (English)

1 reference

13 September 2017

1 reference

1 reference

neoplastic stem cells

1 reference

Qiuhua Wu

1

1 reference

13 September 2017

Rongjiao Guo

2

1 reference

13 September 2017

Min Lin

3

1 reference

13 September 2017

Bing Zhou

4

1 reference

13 September 2017

Yifeng Wang

5

1 reference

13 September 2017

language of work or name

English

0 references

publication date

6 May 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

122

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

149-154

1 reference

Beyond tumorigenesis: cancer stem cells in metastasis

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Epithelial-mesenchymal transitions in development and pathologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Endogenous human microRNAs that suppress breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Identification of the role of Smad interacting protein 1 (SIP1) in glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

Prediction of mammalian microRNA targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

A combined computational-experimental approach predicts human microRNA targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.03.026

10.1016/J.YGYNO.2011.03.026

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference